Skip to main content
. Author manuscript; available in PMC: 2008 Aug 31.
Published in final edited form as: Biochemistry. 2006 Nov 30;45(51):15216–15223. doi: 10.1021/bi0619021

Figure 2.

Figure 2

(A) LpxC substrate, UDP –{3-O-[(R)-3-hydroxymyristoyl]}-N-acetylglucosamine. (B) Substrate analogue inhibitor, TU-514 (Ki ~ 650 nM (27)). (C) uridine 5′-diphosphate (UDP).